Novartis AG - Client Video

Customer:
Novartis AG

Industry:
Healthcare

Deployment country:
Switzerland

Solution:
Enterprise Content Management, Information Lifecycle Governance (ILG), Smarter Analytics

The multinational pharmaceutical company, based in Basel, Switzerland, ranks three in sales among the world-wide industry with US$50.624 billion in 2010. The company has 119,418 employees and a diverse portfolio of healthcare products, including innovative pharmaceuticals, eye care products, generics, consumer healthcare products, and vaccines and diagnostic tools.

Business need:
Novartis required an efficient, defensible approach to retain information of business value or subject to regulatory requirement, preserve information needed for litigation and discard unnecessary information.

Solution:
Novartis implemented IBM Global Retention Policy and Schedule Management to reduce litigation and compliance risk with defensible, routine disposal of unnecessary information.

Benefits:
• Ten-fold increase in ability to dispose of unnecessary information • Lower litigation and regulatory compliance risk • Lower cost with defensible, routine disposal of unnecessary data not needed for legal or business reasons

IBM products and services that were used in this case study.

Software:
Atlas eDiscovery Process Management, Global Retention Policy and Schedule Management

© Copyright IBM Corporation 2012 IBM Corporation Software Group Route 100 Somers, NY 10589 U.S.A. Produced in the United States of America December 2011 All Rights Reserved IBM, the IBM logo, and ibm.com are trademarks or registered trademarks of International Business Machines Corporation in the United States, other countries, or both. If these and other IBM trademarked terms are marked on their first occurrence in this information with a trademark symbol (® or ™), these symbols indicate U.S. registered or common law trademarks owned by IBM at the time this information was published. Such trademarks may also be registered or common law trademarks in other countries. A current list of IBM trademarks is available on the Web at “Copyright and trademark information” at ibm.com/legal/copytrade.shtml Other product, company or service names may be trademarks or service marks of others. This case study is an example of how one customer uses IBM products. There is no guarantee of comparable results. References in this publication to IBM products and services do not imply that IBM intends to make them available in all countries in which IBM operates.